Results 41 to 50 of about 161 (131)
Background: Atopic dermatitis (AD) in dogs is a prevalent allergic disorder associated with environmental allergens, including the house dust mite Dermatophagoides farinae (Df). Hypothesis/Objectives: To describe clinical and immunological changes over time in dogs with canine (c)AD sensitised to Df undergoing Df allergen‐specific immunotherapy (ASIT ...
Jakaphan Wannawong +8 more
wiley +1 more source
Background: Otitis externa (OE) with Malassezia pachydermatis overgrowth with limited bacterial involvement is common in dogs. Treatment with products containing antibiotics is unnecessary and not consistent with judicious use of antimicrobials.
Zorica Zivkovic Baks +4 more
wiley +1 more source
Nemolizumab for Pruritus Control in Cutaneous T‐Cell Lymphoma: A Case Series
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela +2 more
wiley +1 more source
ABSTRACT Background Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous ...
Ralf S. Mueller +4 more
wiley +1 more source
S1PR3 mediates itch and pain via distinct TRP channel-dependent pathways
Sphingosine 1-phosphate (S1P) is a bioactive signaling lipid associated with a variety of chronic pain and itch disorders. S1P signaling has been linked to cutaneous pain, but its role in itch has not yet been studied. Here we find that S1P triggers itch
Rachel B. Brem +3 more
core +1 more source
Yixuan Wang, Sisi Cao, Kaiyue Yu, Fengdie Yang, Xiuming Yu, Yuanhao Zhai, Chuanbin Wu, Yuehong XuDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People’s Republic of ChinaBackground: Topical
Wang Y +7 more
doaj
In 71 dogs with allergic otitis externa receiving proactive hydrocortisone aceponate maintenance therapy after clinical and cytological remission, 70.4% had no relapse and 87.3% had no relapse or only one relapse during a fixed 12‐month observation period.
Elisa Maina +4 more
wiley +1 more source
Placebo arms show substantial improvement in cholestatic pruritus, with up to 30% response rate. Estimates differed across outcome instruments, highlighting the importance of endpoint selection and realistic placebo assumptions in future trial design.
Igor Boechat Silveira +8 more
wiley +1 more source
Among 200 patients with primary sclerosing cholangitis, 38% reported moderate to severe pruritus in the past 6 months. During 6 months of follow up, pruritus severity fluctuated significantly. Pruritus severity was linked to worse colitis activity and lower quality of life.
Richard Dean +16 more
wiley +1 more source
TOPICAL THERAPY IN PEDIATRIC DERMATOLOGY [PDF]
RESUMO Todos sabemos que as crianças não são meramente pequenos adultos. Em comparação com aqueles, estas apresentam uma relação superfície cutânea/ peso corporal aumentada que contribui, por um lado, para aumentar a susceptibilidade à irritação ...
Horta, M., Rocha, N., Selores, M.
core

